Seeking Alpha

Not much new in Mayo Geron article: Needham

  • Needham's Chad Messer doesn't see "a whole lot that is new" in the Mayo Clinic article highlighting Geron's (GERN +8.7%) imetelstat.
  • "We remain positively inclined towards the data but feel investors should wait for full presentation, as well as GERN's investor event, on Monday to understand the full story," Messer adds.
Comments (1)
  • Sacre Bleu
    , contributor
    Comments (8) | Send Message
    The price is noodling along in anticipation. Monday is supposed to be a report from $GERN
    8 Dec 2013, 10:54 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector